Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
bioMerieux
bioMerieux
Activities:
Regulatory
Analysis
Trending Articles
Samsung Biologics earns EcoVadis Platinum Sustainability Rating
The CDMO has been ranked in the top one per cent of companies assessed by EcoVadis, reflecting strengthened sustainability management across environment, labour and human...
High Shear = Mixing Success
19 February 2026 | Virtual
Indonesia looks to oral GLP-1s as it battles rising obesity
Novo Nordisk's oral GLP-1 therapy for chronic weight management could help the country deliver injectable-comparable weight loss alongside cardiovascular risk-reduction...
Autopack highlights best in class solutions at Packaging Innovations and Empack 2026
Leading independent integrator of packaging lines Autopack will showcase a range of its automated and semi-automated equipment at Packaging Innovations and Empack 2026, which...
You need to be a subscriber to read this article.
Click here
to find out more.
Why ethics is more important than ever
IChemE reaffirms its commitment with a new Code of Conduct and Ethics
Upcoming event
High Shear = Mixing Success
19 February 2026 | Virtual
See all
Related Content
Regulatory
bioMérieux and JMI Laboratories partner to fight antimicrobial resistance
JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery
InDevR raises $9m in series B financing
ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory
bioMérieux receives FDA clearance for mass spectrometry ID system
With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing
Recombinant Factor C assay to aid demand for LAL endotoxin testing
Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis
bioMérieux launches automated diagnostic solution for microbial detection
EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance
BioMérieux acquires Hyglos for a total consideration of €24m
Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis
Revolutionised and Robust: Environmental Identification Webinar - mid-October
Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now